English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [916]
News [2620]
Articles [112]
Editorials [3]
Conferences [85]
elearning [27]
Crizotinib superior to chemo for advanced ALK positive NSCLC
Dr Suresh S. Ramalingam - Emory University, Atlanta, USA
Crizotinib superior to chemo for advanced ALK positive NSCLC ( Dr Suresh S. Ramalingam - Emory University, Atlanta, USA )
6 Jun 2013
Comment on progression free survival in lung cancer patients and the GALAXY-1...
Dr Marjorie G. Zauderer - Memorial Sloan-Kettering Cancer Center, New York, USA
Comment on progression free survival in lung cancer patients and the GALAXY-1 trial ( Dr Marjorie G. Zauderer - Memorial Sloan-Kettering Cancer Center, New York, USA )
3 Jun 2013
Ganetespib inhibits Hsp90 with docetaxel for advanced lung cancer
Dr Suresh S. Ramalingam - Emory University, Atlanta, USA
Ganetespib inhibits Hsp90 with docetaxel for advanced lung cancer ( Dr Suresh S. Ramalingam - Emory University, Atlanta, USA )
3 Jun 2013
Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab
Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA
Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab ( Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA )
3 Jun 2013
Nivolumab blocking PD1 in lung cancer and melanoma
Dr Suzanne Topalian - Johns Hopkins Medical Center, Baltimore, USA
Nivolumab blocking PD1 in lung cancer and melanoma ( Dr Suzanne Topalian - Johns Hopkins Medical Center, Baltimore, USA )
3 Jun 2013
Crizotinib and molecular testing in advanced non small cell lung cancer
Dr Fred Hirsch - University of Colorado, Denver, USA
Crizotinib and molecular testing in advanced non small cell lung cancer ( Dr Fred Hirsch - University of Colorado, Denver, USA )
3 Jun 2013
Nintedanib in combination with standard second line therapy in lung cancer
Dr Martin Reck - Hospital Grosshansdorf, Wohrendamm, Germany
Nintedanib in combination with standard second line therapy in lung cancer ( Dr Martin Reck - Hospital Grosshansdorf, Wohrendamm, Germany )
3 Jun 2013
Ganetespib inhibits Hsp90 effective as second-line therapy with docetaxel for...
Dr Suresh S. Ramalingam - Emory University, Atlanta, USA
Ganetespib inhibits Hsp90 effective as second-line therapy with docetaxel for advanced lung cancer ( Dr Suresh S. Ramalingam - Emory University, Atlanta, USA )
3 Jun 2013
New targets for squamos cell carcinoma
Dr Martin Reck – Hospital Grosshansdorf, Wohrendamm, Germany
New targets for squamos cell carcinoma ( Dr Martin Reck – Hospital Grosshansdorf, Wohrendamm, Germany )
16 May 2013
Surgery in mesothelioma
Dr Paul Baas - Netherlands Cancer Institute, Amsterdam
Surgery in mesothelioma ( Dr Paul Baas - Netherlands Cancer Institute, Amsterdam )
16 May 2013
Advances and perspectives on biomarkers
Dr Nicola Normanno - Institute Fondazione Pascale, Naples, Italy
Advances and perspectives on biomarkers ( Dr Nicola Normanno - Institute Fondazione Pascale, Naples, Italy )
16 May 2013
European Thoracic Oncology Platform
Dr Solange Peters - Lausanne University, Switzerland
European Thoracic Oncology Platform ( Dr Solange Peters - Lausanne University, Switzerland )
16 May 2013
<1...6364656667...77>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top